Company · CIK 1971387

# Liminatus Pharma, Inc.

| CIK | [1971387](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001971387) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | LIMN (Nasdaq), LIMNW (Nasdaq) |
| First annual or quarterly report | 2025-06-02 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-296986 | Registered company Filed | 2026-06-24 | 2026-06-24 | 1 |
| 333-293364 | Registered company Final prospectus | 2026-02-11 | 2026-02-18 | 3 |
| 333-288289 | Registered company Effective | 2025-06-24 | 2025-08-12 | 3 |

## Filings

 11

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-06-24 | [S-1](https://www.sec.gov/Archives/edgar/data/1971387/000110465926076958/0001104659-26-076958-index.htm) Registration filed | 333-296986 | 0001104659-26-076958 |
| 2026-02-18 | [424B4](https://www.sec.gov/Archives/edgar/data/1971387/000110465926016706/0001104659-26-016706-index.htm) Final prospectus | 333-293364 | 0001104659-26-016706 |
| 2026-02-13 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1971387/999999999526000587/9999999995-26-000587-index.htm) Declared effective | 333-293364 | 9999999995-26-000587 |
| 2026-02-11 | [S-1](https://www.sec.gov/Archives/edgar/data/1971387/000110465926012942/0001104659-26-012942-index.htm) Registration filed | 333-293364 | 0001104659-26-012942 |
| 2025-12-31 | [DRS](https://www.sec.gov/Archives/edgar/data/1971387/000110465925125670/0001104659-25-125670-index.htm) Draft made public | 377-08901 | 0001104659-25-125670 |
| 2025-08-12 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1971387/999999999525002576/9999999995-25-002576-index.htm) Declared effective | 333-288289 | 9999999995-25-002576 |
| 2025-07-28 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1971387/000141057825001518/0001410578-25-001518-index.htm) Amendment | 333-288289 | 0001410578-25-001518 |
| 2025-06-24 | [S-1](https://www.sec.gov/Archives/edgar/data/1971387/000141057825001432/0001410578-25-001432-index.htm) Registration filed | 333-288289 | 0001410578-25-001432 |
| 2025-02-06 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1971387/999999999525000331/9999999995-25-000331-index.htm) Declared effective | 333-275409 | 9999999995-25-000331 |
| 2024-08-09 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1971387/999999999524002472/9999999995-24-002472-index.htm) Declared effective | 333-275409 | 9999999995-24-002472 |
| 2023-05-02 | [DRS](https://www.sec.gov/Archives/edgar/data/1971387/000110465923054602/0001104659-23-054602-index.htm) Draft made public | 377-06696 | 0001104659-23-054602 |

[All filings of this company](https://equitycapital.markets/filings?cik=1971387) · [CSV](https://equitycapital.markets/filings.csv?cik=1971387)

---
Source page: https://equitycapital.markets/company/1971387 · Data: U.S. SEC EDGAR · CC BY 4.0